- Home
- NMT vs ANIX Comparison
NMT vs ANIX Comparison
Compare NMT & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMT | ANIX |
|---|---|---|
| Founded | 1993 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.8M | 104.0M |
| IPO Year | N/A | 1987 |
Fundamental Metrics
Financial Performance| Metric | NMT | ANIX |
|---|---|---|
| Price | $11.53 | $3.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 19.1K | ★ 215.0K |
| Earning Date | 01-01-0001 | 01-12-2026 |
| Dividend Yield | ★ 3.21% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.05 | $2.33 |
| 52 Week High | $10.93 | $5.46 |
Technical Indicators
Market Signals| Indicator | NMT | ANIX |
|---|---|---|
| Relative Strength Index (RSI) | 56.93 | 44.45 |
| Support Level | $11.39 | $3.06 |
| Resistance Level | $11.60 | $3.36 |
| Average True Range (ATR) | 0.10 | 0.17 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 81.48 | 36.54 |
Price Performance
Historical ComparisonAbout NMT Nuveen Massachusetts Quality Municipal Income Fund
Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes and to enhance portfolio value relative to the Massachusetts municipal bond market by investing in tax-exempt Massachusetts municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.